principal investigators
Maxine Stitzer


Maxine Stitzer, Co-Investigator

Dr. Stitzer is the Co-Principal Investigator (with Dr. Robert Schwartz of Friends Research Institute) at the
Mid-Atlantic Node of the NIDA Clinical Trials Network.  Dr. Stitzer has long maintained an extensive
grant-supported research program focused on both pharmacological and behavioral approaches to the
treatment of substance abuse and tobacco dependence. A recognized leader, well known for her seminal
work on contingency management approaches in substance abuse treatment, she is especially interested in developing interventions that can motivate positive behavior change. She was the Principal Investigator on
the first national multi-site trial of abstinence incentives' effectiveness when implemented in community drug
treatment programs funded by the National Institute on Drug Abuse (NIDA).

 



Robert Schwartz



Robert Schwartz, Principal Investigator

Dr. Schwartz is the Co-Principal Investigator (with Dr. Maxine Stitzer of Johns Hopkins) of the Mid-Atlantic
Node of the NIDA Clinical Trials Network. He is psychiatrist who serves as the Medical Director of Friends
Research Institute and is the former Director of the Division of Alcohol and Drug Abuse at the University of
Maryland School of Medicine. Dr. Schwartz is Principal Investigator of three NIDA-funded clinical trials which
are examining: (1) a novel approach to re-engineering methadone treatment programs; (2) computerized brief interventions for drug misuse among primary care patients in New Mexico; and, (3) methadone treatment
and patient navigation as a pre-release strategy from incarceration. Dr. Schwartz serves on the NIH Center for
Scientific Review’s Health Services Organization and Delivery Study Section.


 


 


 



 

 

 

 

 

 

 

 

 

 

 

 

Home home homepage